Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1103-1110

  Kura, Aminu Umar ^a   Ali, Samer Hasan Hussein Al ^a   Hussein, Mohd Zobir ^b   Fakurazi, Sharida ^a,c   Arulselvan, Palanisamy ^a  

^a Universi ty Putra Malaysia   (Malaysia)

^b Institute of Advanced Technology   (Malaysia)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Coprecipitation; Layered double hydroxide; Levodopa; Sustained release

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HYDROTALCITE; LEVODOPA; NANOCOMPOSITE; UNCLASSIFIED DRUG; ZINC ALUMINUM;

ANIMAL CELL; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BIOCOMPATIBILITY; CELL VIABILITY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; NANOTECHNOLOGY; NONHUMAN; PARKINSON DISEASE; RAT; SURFACE PROPERTY; THERMAL ANALYSIS; THERMOGRAVIMETRY; X RAY DIFFRACTION;

COPRECIPITATION; LAYERED DOUBLE HYDROXIDE; LEVODOPA; SUSTAINED RELEASE;

3T3 CELLS; ALUMINUM; ANIMALS; ANTIPARKINSON AGENTS; CELL SURVIVAL; CHEMICAL PRECIPITATION; DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; HYDROXIDES; LEVODOPA; MICE; NANOCOMPOSITES; SURFACE PROPERTIES; ZINC;

EID: 84875297289     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S39740     Document Type: Article

References (23)

1. Poewe W, Antonini A, Zijlmans JCM, Burkhard PR, Vingerhoets F. Levodopa in the treatment of Parkinson's disease: an old drug still going strong. Clin Interv Aging. 2010;5:229-238.
2. Aviles-Olmos I, Martinez-Fernandez R, Foltynie T. L-dopa-induced dyskinesias in Parkinson's disease. Eur Neurol J. 2010;2(2):91-100.
3. Choi SJ, Oh JM, Choy JH. Anticancer drug-layered hydroxide nanohy- brids as potent cancer chemotherapy agents. J Phys Chem Solids. 2008; 69(5-6):1528-1532.
4. Vergoni AV, Tosi G, Tacchi R, Vandelli MA, Bertolini A, Costantino L. Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. Nanomedicine. 2009;5(4):369-377.
5. Silion M, Popa MI, Lisa G, Hritcu D. New hybrid compounds containing intercalated ciprofoxacin into layered double hydroxides: synthesis and characterization. Revue Roumaine de Chimie. 2008;53(9):827-831.
6. Del Arco M, Cebadera E, Gutierrez S, et al. Mg, Al layered double hydroxides with intercalated indomethacin: synthesis, characterization, and pharmacological study. J Pharm Sci. 2004;93(6):1649-1658.
7. Wong Y, Markham K, Xu Z P, et al. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles. Biomaterials. 2010;31(33):8770-8779.
8. Flesken-Nikitin A, Toshkov I, Naskar J, et al. Toxicity and bio- medical imaging of layered nanohybrids in the mouse. Toxicol Pathol. 2007;35(6):804-810.
9. Xu Z P, Lu GQ. Layered double hydroxide nanomaterials as potential cellular drug delivery agents. Pure Appl Chem. 2006;78(9): 1771-1780.
10. Kovanda F, Jindova E, Dousova B, Kolousek D, Plestil J, Sedlakova Z. Layered double hydroxides intercalated with organic anions and their application in preparation of LDH/polymer nanocomposites. Acta Geodyn Geomater. 2009;6:111-119.
11. Li F, Jin L, Han J, Wei M, Li C. Synthesis and controlled release properties of prednisone intercalated Mg-Al layered double hydroxide composite. Ind Eng Chem Res. 2009;48(12):5590-5597.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):56-83.
13. Xia SJ, Ni ZM, Xu Q, Hu BX, Hu J. Layered double hydroxides as sup- ports for intercalation and sustained release of antihypertensive drugs. J Solid State Chem. 2008;181(10):2610-2619.
14. Al Ali SHH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN. Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. Int J Nanomedicine. 2012;7: 2129-2141.
15. Yaghi OM, Li H. T-Shaped molecular building units in the porous struc- ture of Ag (4, 4′-bpy). NO3. J Am Chem Soc. 1996;118(1):295-296.
16. Tyner KM, Schiffman SR, Giannelis E P. Nanobiohybrids as delivery vehicles for camptothecin. J Control Release. 2004;95(3):501-514.
17. Dong L, Yan L, Hou W-G, Liu S-J. Synthesis and release behavior of composites of camptothecin and layered double hydroxide. J Solid State Chem. 2010;183(8):1811-1816.
18. Ho YS, Ofomaja AE. Pseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fber. J Hazard Mater. 2006; 129(1-3):137-142.
19. Kong X, Shi S, Han J, Zhu F, Wei M, Duan X. Preparation of glycy lyrosine intercalated layered double hydroxide film and its in vitro release behavior. Chem Eng J. 2010;157(2-3):598-604.
20. Al Ali SHH, Al-Qubaisi M, Hussein MZ, Zainal Z, Hakim MN. Con- trolled release and angiotensin-converting enzyme inhibitor properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. Int J Nanomedicine. 2012;7:2129-2141.
21. Hussein MZ, Al Ali SH, Zainal Z, Hakim MN. Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent. Int J Nanomedicine. 2011;6: 1373-1383.
22. Xu FJ. Preparation and evaluation of well-defined hemocompatible layered double hydroxide-poly (sulfobetaine) nanohybrids. J Mater Chem. 2012;22(30):15362-15369.
23. Hussein-Al-Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN. In vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al-and Mg/Al-layered double hydroxides. Int J Mol Sci. 2012;13(5):5899-5916.